Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Community Delivery of a Comprehensive Fall-Prevention Program in People with Multiple Sclerosis: A Retrospective Observational Study.
Impact of cost sharing on specialty drug utilization and outcomes: a review of the evidence and future directions.
Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease.
Are there evidence-based dietary interventions for multiple sclerosis?
Visual pathway abnormalities were found in most multiple sclerosis patients despite history of previous optic neuritis.
[Multiple sclerosis and pregnancy].
Subcutaneous IgG in neurologic diseases.
SIRT1 is decreased during relapses in patients with multiple sclerosis.
Can the Fatigue Severity Scale 7-item version be used across different patient populations as a generic fatigue measure - a comparative study using a Rasch model approach.
Should optical coherence tomography be used to manage patients with multiple sclerosis?
Multiple sclerosis, an unlikely cause of chronic cerebrospinal venous insufficiency: retrospective analysis of catheter venography.
TWEAK/Fn14 pathway modulates properties of a human microvascular endothelial cell model of blood brain barrier.
Use of Functional Ambulation Performance Score as measurement of gait ability: Review.
A Survey of Severity and Distribution of Musculoskeletal Pain in Multiple Sclerosis Patients; a Cross-Sectional Study.
Integrating the ICF with positive psychology: Factors predicting role participation for mothers with multiple sclerosis.
Coping Mediates and Moderates the Relationship Between Executive Functions and Psychological Adjustment in Multiple Sclerosis .
Bilateral hypogeusia caused by a small lesion in the lower midbrain tegmentum.
Multiple sclerosis: Cognitive training provides lasting benefits for patients with multiple sclerosis.
The human JC polyomavirus (JCPyV): virological background and clinical implications.
Glutamate signaling in benign and malignant disorders: current status, future perspectives, and therapeutic implications.
Role of intravenous immunoglobulin in the treatment of acute relapses of neuromyelitis optica: experience in 10 patients.
Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis.
Autoimmune T-Cell Reactivity to Myelin Proteolipids and Glycolipids in Multiple Sclerosis.
Progressive resistance therapy is not the best way to rehabilitate deficits due to multiple sclerosis: Yes.
Embryonic stem cells in multiple sclerosis.
Pages
« first
‹ previous
…
408
409
410
411
412
413
414
415
416
…
next ›
last »